Frontlight ResearchEarly access
Migraine trials, also abroad
258 open Migraine trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig) has 1 site in Finland and runs in 2 countries. If a site near you is full, another one may still take people.
See The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig) in all 2 countries